Functional characterization of two S-nitroso-l-cysteine transporters, which mediate movement of NO equivalents into vascular cells
Authors:
- A. Richard WhortonAWA. Richard Whorton
- 1 April 2007
- journal article
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 292 (4) , C1263-C1271
Abstract
System L amino acid transporters have been shown to be responsible for cellular uptake of S-nitroso-l-cysteine (l-CSNO). In this study, we examined the characteristics of l-CSNO uptake in Xenopus laevis oocytes expressing system L transporters and found that uptake increased only when both 4F2 heavy chain (4F2HC) and either L-type amino acid transporter 1 (LAT1) or LAT2 light chain were coexpressed. The Km for transport was 57 ± 8 μM for 4F2HC-LAT1 and 520 ± 52 μM for 4F2HC-LAT2. Vascular endothelial and smooth muscle cells were shown to express transcripts for 4F2HC and for both LAT1 and LAT2. Transport of l-CSNO into red blood cells, endothelial cells, and smooth muscle cells was inhibited by 2-aminobicyclo(2.2.1)heptane-2-carboxylic acid (BCH) and by large neutral amino acids demonstrating functional system L transporters in each cell type. Uptake of l-CSNO led to accumulation of cellular S-nitrosothiols and inhibition of both growth factor-induced ERK phosphorylation and TNF-α-mediated IκB degradation. Similar effects were seen when cells were incubated simultaneously with S-nitrosoalbumin and l-cysteine but not with d-cysteine or with S-nitrosoalbumin alone. In each case, nitrosylation of proteins and cellular responses were blocked by BCH. Together, these data suggest that transmembrane movement of nitric oxide (NO) equivalents from the plasma albumin NO reservoir is mediated by cysteine, which serves as a carrier. The mechanism requires transnitrosylation from S-nitrosoalbumin to free cysteine and activity of system L transporters, thereby providing a unique pathway for cellular responses to S-nitrosoalbumin.Keywords
This publication has 42 references indexed in Scilit:
- The use of N-acetylcysteine for the prevention of hypertension in the reduced uterine perfusion pressure model for preeclampsia in Sprague-Dawley ratsAmerican Journal of Obstetrics and Gynecology, 2005
- Specific transport of S‐nitrosocysteine in human red blood cells: Implications for formation of S‐nitrosothiols and transport of NO bioactivity within the vasculatureFEBS Letters, 2005
- Role of Circulating S -Nitrosothiols in Control of Blood PressureHypertension, 2005
- S -Nitrosoalbumin–Mediated Relaxation Is Enhanced by Ascorbate and CopperHypertension, 2005
- N-acetylcysteine restores nitric oxide–mediated effects in the fetoplacental circulation of preeclamptic patientsAmerican Journal of Obstetrics and Gynecology, 2004
- Nitric Oxide in Health and Disease of the Respiratory SystemPhysiological Reviews, 2004
- Oxidized and free whole blood thiols in preeclampsiaObstetrics & Gynecology, 2001
- S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular controlNature, 1996
- In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols.Journal of Clinical Investigation, 1994
- NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties.Journal of Clinical Investigation, 1993